{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-22-000146","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.262994+00:00","generated_at":"2026-06-22T22:19:14.683940+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Quest Diagnostics increases CEO Davis's salary to $1.1M, grants $5M equity upon promotion","bullets":["CEO Davis base salary raised to $1.1M, target annual incentive 150% of salary, effective Nov 1, 2022.","Equity grant of $5M: 60% performance shares (vest Feb 2025) and 40% RSUs (3-year cliff vest).","Transportation benefit up to $175k/yr; relocation benefits $125k flexible plus $25k legal/tax.","Davis moved to Schedule A of severance plan; share ownership guideline increased to 6x salary."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-22-000146","json":"https://secwatch.observer/filing/0001022079-22-000146.json","markdown":"https://secwatch.observer/filing/0001022079-22-000146.md","text":"https://secwatch.observer/filing/0001022079-22-000146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000146/0001022079-22-000146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000146/dgx-20221028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:19:14.683940+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d46930999a","claim":"James Davis changed role as Chief Executive Officer and President at QUEST DIAGNOSTICS INC.","evidence_excerpt":"On October 28, 2022, the Compensation Committee (the “Committee”) of the Board of Directors of Quest Diagnostics Incorporated (the “Company”) approved an updated compensation package for Mr. Davis, reflecting Mr. Davis becoming Chief Executive Officer and President of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207922000146/0001022079-22-000146-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Executive Officer and President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}